These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27289450)

  • 1. Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages.
    Samantaray S; Correia JN; Garelnabi M; Voelz K; May RC; Hall RA
    Int J Antimicrob Agents; 2016 Jul; 48(1):69-77. PubMed ID: 27289450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
    Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
    Aaron PA; Vu K; Gelli A
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.
    Levitz SM; Harrison TS; Tabuni A; Liu X
    J Clin Invest; 1997 Sep; 100(6):1640-6. PubMed ID: 9294133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aminoalkylindole BML-190 Negatively Regulates Chitosan Synthesis via the Cyclic AMP/Protein Kinase A1 Pathway in Cryptococcus neoformans.
    Maybruck BT; Lam WC; Specht CA; Ilagan MXG; Donlin MJ; Lodge JK
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848271
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.
    Pereira de Sá N; Lino CI; Fonseca NC; Borelli BM; Ramos JP; Souza-Fagundes EM; Rosa CA; Santos DA; Barbosa de Oliveira R; Johann S
    Eur J Med Chem; 2015 Sep; 102():233-42. PubMed ID: 26276437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Fungus-Specific Targets and Inhibitors Using Chemical Phenotyping of Pathogenic Spore Germination.
    Ortiz SC; Huang M; Hull CM
    mBio; 2021 Aug; 12(4):e0167221. PubMed ID: 34311572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans.
    Cao C; Wang Y; Husain S; Soteropoulos P; Xue C
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans.
    Harrison TS; Griffin GE; Levitz SM
    J Infect Dis; 2000 Jul; 182(1):283-9. PubMed ID: 10882608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans.
    Rabjohns JLA; Park YD; Dehdashti J; Henderson C; Zelazny A; Metallo SJ; Zheng W; Williamson PR
    J Biomol Screen; 2014 Feb; 19(2):270-277. PubMed ID: 23896686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyaldimines as potent in vitro anticryptococcal agents.
    Magalhães TF; da Silva CM; de Fátima Â; da Silva DL; Modolo LV; Martins CV; Alves RB; Ruiz AL; Longato GB; de Carvalho JE; de Resende-Stoianoff MA
    Lett Appl Microbiol; 2013 Aug; 57(2):137-43. PubMed ID: 23594040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
    Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
    mBio; 2016 May; 7(3):. PubMed ID: 27165800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory activity of β-glucan-containing exopolysaccharides from Auricularia auricular in phagocytes and mice infected with Cryptococcus neoformans.
    Basso AMM; De Castro RJA; de Castro TB; Guimarães HI; Polez VLP; Carbonero ER; Pomin VH; Hoffmann C; Grossi-de-Sa MF; Tavares AH; Bocca AL
    Med Mycol; 2020 Feb; 58(2):227-239. PubMed ID: 31095342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages.
    Alvarez M; Casadevall A
    Curr Biol; 2006 Nov; 16(21):2161-5. PubMed ID: 17084702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation.
    Johnston SA; May RC
    PLoS Pathog; 2010 Aug; 6(8):e1001041. PubMed ID: 20714349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH.
    Nicola AM; Robertson EJ; Albuquerque P; Derengowski Lda S; Casadevall A
    mBio; 2011; 2(4):. PubMed ID: 21828219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide as a novel anticryptococcal agent.
    Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
    Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcus neoformans
    Zhang L; Zhang K; Li H; Coelho C; de Souza Gonçalves D; Fu MS; Li X; Nakayasu ES; Kim YM; Liao W; Pan W; Casadevall A
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.